3N-substituted 3,4-dihydropyrimidines as agents for treating disorders
申请人:Suntory Limited
公开号:US04640922A1
公开(公告)日:1987-02-03
A 3N-substituted 3,4-dihydropyrimidine derivative of the formula: ##STR1## wherein R.sup.1 is methyl or ethyl, R.sup.2 is methyl or ethyl, R is phenyl or substituted phenyl, X is chloro or methyl and pharmaceutically acceptable acid addition salts thereof have substantially the same strong vasodilative and Ca.sup.++ antagonistic effects as nicardipine and therefore are useful as agents for treating disorders of the cardiovascular system, for example, hypotensive agents, agents for amelioration of brain circulation and anti-angina pectoris agents. Processes for producing the above compounds economically and effectively are also disclosed.
3N-substituted 3,4-dihydropyrimidine derivatives, processes for preparing them and pharmaceutical compositions
申请人:SUNTORY LIMITED
公开号:EP0157219A1
公开(公告)日:1985-10-09
A 3N-substituted 3,4-dihydropyrimidine derivative of the formula:
wherein R' is methyl or ethyl, R2 is methyl or ethyl, R is phenyl or substituted phenyl, X is chloro or methyl and pharmaceutically acceptable acid addition salts thereof have in form of pharmaceutical compositions substantially the same strong vasodilative and Ca++ antagonistic effects as nicardipine and therefore are useful as agents for treating disorders of the cardiovascular system, for example, hypotensive agents, agents for amelioration of brain circulation and anti-angina pectoris agents.
Processes for producing the above compounds economically and effectively are also disclosed.